PT Kalbe Farma Tbk. (PTKFY)
PNK: PTKFY
· Real-Time Price · USD
18.41
2.41 (15.06%)
At close: May 01, 2025, 3:30 PM
15.06% (1D)
| Bid | 14.28 |
| Market Cap | 21.15M |
| Revenue (ttm) | 32,627.8B |
| Net Income (ttm) | 3,240.6B |
| EPS (ttm) | 0.84 |
| PE Ratio (ttm) | 21.92 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 18.58 |
| Volume | 43 |
| Avg. Volume (20D) | 375 |
| Open | 18.41 |
| Previous Close | 16.00 |
| Day's Range | 18.41 - 18.41 |
| 52-Week Range | 11.44 - 23.73 |
| Beta | 0.16 |
About PTKFY
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. It offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Aug 13, 2012
Employees 12,903
Stock Exchange PNK
Ticker Symbol PTKFY
Website https://www.kalbe.co.id